Hybrid percutaneous coronary revascularisation for a patient with left main bifurcation and extensive, diffuse coronary artery disease

International Journal of Cardiology

Volumn 173, Issue 2, 2014, Pages

  Panoulas, Vasileios F ^a,b,c   Miyazaki, Tadashi ^b,c   Sato, Katsumasa ^b,c   Naganuma, Toru ^b,c   Latib, Azeem ^b,c   Colombo, Antonio ^b,c  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c EMO GVM CENTRO CUORE COLUMBUS   (Italy)

Author keywords

Bioresorbable vascular scaffolds; Coronary artery disease; Diffuse disease; Drug eluting balloons; Extensive; Left main stem

Indexed keywords

EVEROLIMUS;

AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; BALLOON CATHETER; CASE REPORT; CORONARY ARTERY; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY DISEASE; CORONARY BIFURCATION LESION; DRUG ELUTING BALLOON; DRUG ELUTING STENT; DYSLIPIDEMIA; EVEROLIMUS ELUTING STENT; HEART MUSCLE REVASCULARIZATION; HUMAN; INTRAVASCULAR ULTRASOUND; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LETTER; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; TREADMILL TEST; BIODEGRADABLE IMPLANT; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; PROCEDURES; RADIOGRAPHY; SEVERITY OF ILLNESS INDEX; TISSUE SCAFFOLD;

ABSORBABLE IMPLANTS; AGED; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; HUMANS; MALE; PERCUTANEOUS CORONARY INTERVENTION; SEVERITY OF ILLNESS INDEX; TISSUE SCAFFOLDS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84898858019     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.03.032     Document Type: Article

References (10)

1. J.M. White, J.A. Ormiston, B. Webber, B. Ubod, and M.W.I. Webster Bifurcation strategies with the Absorb BVS everolimus-eluting resorbable scaffold. A bench study Heart Lung Circ 22 2013 591
2. V. Dzavik, T. Muramatsu, N. Crooks, S. Nakatani, and Y. Onuma Complex bifurcation percutaneous coronary intervention with the Absorb bioresorbable vascular scaffold EuroIntervention 9 2013 888
3. R. Valenti, A. Migliorini, and G. Parodi et al. Clinical and angiographic outcomes of patients treated with everolimus-eluting stents or first-generation Paclitaxel-eluting stents for unprotected left main disease J Am Coll Cardiol 60 2012 1217 1222
4. I.T. Meredith, S. Verheye, and C.L. Dubois et al. Primary endpoint results of the EVOLVE trial: a randomized evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent J Am Coll Cardiol 59 2012 1362 1370
5. D. Dudek, Y. Onuma, J.A. Ormiston, L. Thuesen, K. Miquel-Hebert, and P.W. Serruys Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial EuroIntervention 7 2012 1060 1061
6. R. Diletti, V. Farooq, and C. Girasis et al. Clinical and intravascular imaging outcomes at 1 and 2 years after implantation of absorb everolimus eluting bioresorbable vascular scaffolds in small vessels. Late lumen enlargement: does bioresorption matter with small vessel size? Insight from the ABSORB cohort B trial Heart 99 2013 98 105
7. A. Latib, A. Colombo, and F. Castriota et al. A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: the BELLO (Balloon Elution and Late Loss Optimization) study J Am Coll Cardiol 60 2012 2473 2480
8. T. Naganuma, A. Latib, and A. Ielasi et al. No more metallic cages: an attractive hybrid strategy with bioresorbable vascular scaffold and drug-eluting balloon for diffuse or tandem lesions in the same vessel Int J Cardiol 172 3 Apr 1 2014 618 619
9. S. Cassese, R.A. Byrne, and T. Tada et al. Incidence and predictors of restenosis after coronary stenting in 10,004 patients with surveillance angiography Heart 100 2014 153 159
10. F. D'Ascenzo, M. Bollati, and F. Clementi et al. Incidence and predictors of coronary stent thrombosis: evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thromboses Int J Cardiol 167 2013 575 584